FDA.reportPublic FDA data

0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe

RxCUI
2583641
RxNorm name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Display name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Full name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125740TicovacTick-Borne Encephalitis Vaccine351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
da102644-62a9-41c2-8a91-6fc19a03e6f1tick-borne encephalitis purified antigen 1.2 MCG in 0.25 ML Prefilled Syringe [PSN] · 0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe [SCD] · ick-borne encephalitis purified antigen 1.2 MCG per 0.25 ML Prefilled Syringe [SY]37These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection Initial U.S. Approval: 202120260317